The Safety, Tolerability, and Immunogenicity of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Subject Infected With HIV Who are Either Previously Vaccinated or Vaccinia Naive: A Double-Blind, Placebo-Controlled, Phase 1/2 Study

Grants and Contracts Details

StatusFinished
Effective start/end date9/1/05 → 8/31/10

Funding

  • Acambis Inc: $5,670.00